Seroprevalence of antibodies against Borrelia burgdorferi and Anaplasma phagocytophilum in cats

American Journal of Veterinary Research

Volumn 66, Issue 11, 2005, Pages 1895-1899

  Magnarelli, Louis A ^a   Bushmich, Sandra L ^b   Ijdo, Jacob W ^c,d   Fikrig, Erol ^c  

^a Connecticut Agricultural Experiment Station ^*  (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; OUTER SURFACE PROTEIN A; RECOMBINANT ANTIGEN;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL LAMENESS; ANOREXIA; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; BORRELIA BURGDORFERI; CAT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; INFESTATION; IXODES SCAPULARIS; NONHUMAN; SEROPREVALENCE; SUPERINFECTION; UNITED STATES; WESTERN BLOTTING; WHOLE CELL;

ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BLOTTING, WESTERN; BORRELIA BURGDORFERI; CAT DISEASES; CATS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; LYME DISEASE; NEW ENGLAND; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

ACARI; ANAPLASMA PHAGOCYTOPHILUM; ANIMALIA; BACTERIA (MICROORGANISMS); BORRELIA BURGDORFERI; IXODES SCAPULARIS;

EID: 30744464841     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.1895     Document Type: Article

References (36)

1. Magnarelli LA, Anderson JF, Johnson RC. Cross-reactivity in serological tests for Lyme disease and other spirochetal infections. J Infect Dis 1987;156:183-188.
2. Magnarelli LA, Miller JN, Anderson JF, et al. Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease. J Clin Microbiol 1990;28:1276-1279.
3. Rogers AB, Smith RD, Kakoma I. Serologic cross-reactivity of antibodies against Borrelia theileri, Borrelia burgdorferi and Borrelia conaceae in cattle. Am J Vet Res 1999;60:694-697.
4. Magnarelli LA, Anderson JF, Levine HR, et al. Tick parasitism and antibodies to Borrelia burgdorferi in cats. J Am Vet Med Assoc 1990;197:63-66.
5. Mathiesen MJ, Christiansen M, Hansen K, et al. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J Clin Microbiol 1998;36:3474-3479.
6. IJdo JW, Wu C, Magnarelli LA, et al. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. J Clin Microbiol 1999;37:3540-3544.
7. Magnarelli LA, IJdo JW, Van Andel, et al. Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the northeastern United States. J Am Vet Med Assoc 2000; 217:1045-1050.
8. Magnarelli LA, Lawrenz M, Norris SJ, et al. Comparative reactivity of human sera to recombinant VlsE and other Borrelia burgdorferi antigens in class-specific enzyme-linked immunosorbent assays for Lyme borreliosis. J Med Microbiol 2002;51:649-655.
9. Magnarelli LA, IJdo JW, Sherman BA, et al. Antibodies to granulocytic ehrlichiae in cattle from Connecticut. J Med Microbiol 2002;51:326-331.
10. Heikkila T, Seppala I, Saxen H, et al. Cloning of the gene encoding decorin-binding protein B (DbpB) in Borrelia burgdorferi sensu lato and characterization of the antibody responses to DbpB in Lyme borreliosis. J Med Microbiol 2002;51:641-648.
11. Lawrenz MB, Hardham JM, Owens RT, et al. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol 1999;37:3997-4004.
12. Liang FT, Steere AC, Marques AR, et al. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 1999;37:3990-3996.
13. Liang FT, Jacobson RH, Straubinger RK, et al. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 2000;38:4160-4166.
14. Heikkila T, Huppertz H-I, Seppala I, et al. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J infect Dis 2003;187:1888-1894.
15. Schulte-Spechtel U, Lehnert G, Liegl G, et al. Significant improvement of the recombinant Borrelia-specific immunoglobulin G immunoblot test by addition of VlsE and DbpA homologue derived from Borrelia garinii for diagnosis of early neuroborreliosis. J Clin Microbiol 2003;41:1299-1303.
16. Bacon RM, Biggerstaff BJ, Schriefer ME, et al. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis 2003;187:1187-1199.
17. Magnarelli LA, Meegan JM, Anderson JF, et al. Comparison of an indirect fluorescent-antibody test with an enzyme-linked immunosorbent assay for serological studies of Lyme disease. J Clin Microbiol 1984;20:181-184.
18. Magnarelli L, IJdo J, Wu C, et al. Recombinant protein-44-based class-specific enzyme-linked immunosorbent assays for scrologic diagnosis of human granulocytic ehrlichiosis. Eur J Clin Microbiol Infect Dis 2001;20:482-485.
19. 6 ELISA Lyme disease test for the determination of the infection status of cats naturally exposed to Borrelia burgdorferi. Vet Ther 2003;4:172-177.
20. Manion T, Bushmich SL, Khan M, et al. Suspected clinical Lyme disease in horses: serological and antigen testing differences between clinically ill and clinically normal horses from an endemic region. J Equine Vet Sci 2001;21:231-236.
21. Magnarelli LA, Bushmich SL, Sherman BA, et al. A comparison of scrologic tests for the detection of serum antibodies to whole-cell and recombinant Borrelia burgdorferi antigens in cattle. Can Vet J 2004;45:667-673.
22. Gibson MD, Young CR, Omran MT, et al. Borrelia burgdorferi in cats (lett). J Am Vet Med Assoc 1993;202:1786.
23. Burgess EC. Experimentally induced infection in cats with Borrelia burgdorferi. Am J Vet Res 1992;53:1507-1511.
24. Lappin MR, Breitschwerdt EB, Jensen WA, et al. Molecular and serologic evidence of Anaplasma phagocytophilum infection in cats in North America. J Am Vet Med Assoc 2004;225:893-896.
25. Steere AC. Lyme disease. N Engl J Med 1989;321:586-596.
26. Nadelman RB, Horowitz HW, Hsieh T-C, et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med 1997;337:27-30.
27. Belongia EA. Epidemiology and impact of coinfections acquired from Ixodes ticks. Vector Borne Zoo Dis 2002;2:265-273.
28. Thomas V, Anguita J, Barthold SW, et al. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect Immun 2001;69:3359-3371.
29. Dressler F, Whalen JA, Reinhardt BN, et al. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993; 167:392-400.
30. Stevenson B, El-Hagen N, Hines MA, et al. Differential binding of host complement inhibitor factor H by Borrelia burgdorferi Erp surface proteins: a possible mechanism underlying the expansive host range of Lyme disease spirochetes. Infect Immun 2002;70:491-497.
31. Liang FT, Yan J, Mbow ML, et al. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 2004;72:5759-5767.
32. May C, Carter SD, Barnes A, et al. Borrelia burgdorferi infection in cats in the UK. J Small Anim Pract 1994;35:517-520.
33. Akin E, McHugh GL, Flavell RA, et al. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect Immun 1999;67:173-181.
34. Fikrig E, Barthold SW, Sun W, et al. Borrelia burgdorferi p35 and p37 proteins, expressed in vivo, elicit protective immunity. Immunity 1997;6:531-539.
35. 6 test as an indicator of therapy outcome for patients with localized or disseminated Lyme borreliosis. J Clin Microbiol 2003;41:4955-4960.
36. Peltomaa M, McHugh G, Steere AC. Persistence of the antibody espouse to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J Infect Dis 2003;187:1178-1186.